Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening
- PMID: 18378512
- PMCID: PMC2722102
- DOI: 10.1093/jpepsy/jsn032
Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening
Abstract
Objective: As technology advances, newborn screening will be possible for conditions not screened today. With an expansion of screening, strategies will be needed to support family adaptation to unexpected and possibly uncertain genetic information provided shortly after birth.
Method: Although candidate conditions for expanded newborn screening will typically be associated with increased morbidity or mortality, for most there is no proven medical treatment that must be implemented quickly. Many will have clinical features that gradually emerge and for which the severity of impact is not predictable. Parents will seek guidance on information, support, and treatment possibilities. This article summarizes issues evoked by expanded newborn screening and suggests strategies for supporting families of identified children.
Results: We propose four components necessary to support family adaptation to pre-symptomatic and "untreatable" conditions in an era of expanded newborn screening: (1) accurate and understandable information; (2) formal and informal support; (3) active surveillance; and (4) general and targeted interventions. We argue that no condition is "untreatable" and that a well-designed program of prevention and support has the potential to maximize benefit and minimize harm.
Conclusions: Pediatric psychologists can play important roles in an era of expanded newborn screening by helping families understand genetic information, make informed decisions about genetic testing, and cope with the potential psychosocial consequences of genetic information.
Similar articles
-
Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.J Genet Couns. 2006 Aug;15(4):277-91. doi: 10.1007/s10897-006-9031-x. J Genet Couns. 2006. PMID: 16865559
-
[Ethical and psychological aspects of screening tests for children].Nord Med. 1993;108(11):297-9. Nord Med. 1993. PMID: 8247721 Danish.
-
Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety.Genet Med. 2011 Jul;13(7):658-61. doi: 10.1097/GIM.0b013e31821435f7. Genet Med. 2011. PMID: 21546841
-
Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.Pediatrics. 2008 Mar;121(3):e693-704. doi: 10.1542/peds.2007-0820. Pediatrics. 2008. PMID: 18310190 Review.
-
Predictive genetic testing: psychological factors.J Psychosom Res. 1997 Nov;43(5):477-87. doi: 10.1016/s0022-3999(97)00170-0. J Psychosom Res. 1997. PMID: 9394264 Review.
Cited by
-
Fragile X protein in newborn dried blood spots.BMC Med Genet. 2014 Oct 28;15:119. doi: 10.1186/s12881-014-0119-0. BMC Med Genet. 2014. PMID: 25348928 Free PMC article.
-
A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome.Mol Genet Genomic Med. 2022 Mar;10(3):e1843. doi: 10.1002/mgg3.1843. Epub 2022 Feb 11. Mol Genet Genomic Med. 2022. PMID: 35150089 Free PMC article. Review.
-
Psychosocial impact on mothers receiving expanded newborn screening results.Eur J Hum Genet. 2018 Apr;26(4):477-484. doi: 10.1038/s41431-017-0069-z. Epub 2018 Jan 29. Eur J Hum Genet. 2018. PMID: 29379194 Free PMC article.
-
Early Check: translational science at the intersection of public health and newborn screening.BMC Pediatr. 2019 Jul 17;19(1):238. doi: 10.1186/s12887-019-1606-4. BMC Pediatr. 2019. PMID: 31315600 Free PMC article.
-
A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information.Hastings Cent Rep. 2018 Jul;48 Suppl 2(Suppl 2):S25-S27. doi: 10.1002/hast.880. Hastings Cent Rep. 2018. PMID: 30133727 Free PMC article.
References
-
- Adams RJ. Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. Journal of Child Neurology. 2000;15:344–349. - PubMed
-
- Alexander D, Hanson JW. NICHD research initiative in newborn screening. Mental Retardation and Developmental Disabilities Research Reviews. 2006;12:301–304. - PubMed
-
- American Academy of Pediatrics Committee on Children with Disabilities. Developmental surveillance and screening of infants and young children. Pediatrics. 2001;108:192–195. - PubMed
-
- American Academy of Pediatrics Medical Home Initiatives for Children with Special Needs Project Advisory Committee. The medical home. Pediatrics. 2002;110:184–186. - PubMed
-
- American Academy of Pediatrics Newborn Screening Task Force. Serving the family from birth to the medical home. Newborn screening: A blueprint for the future. Pediatrics. 2000;106(Suppl):389–427. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials